Sorghum (Sorghum bicolor) grain contains many health-promoting phytochemicals, including a broad range of phenolic compounds. Malting of cereal grains is known to increase the bioavailability of macro- and micronutrients. However, the detailed effects of malting on sorghum grain anthocyanins, a major class of phenolics that influence the taste and colour of sorghum-based foods, requires further investigation. Eight commercial sorghum hybrids harvested from three regions in eastern Australia were malted and analysed for colour, tannin content, total phenolic content (TPC), flavan-4-ols, total flavonoids, total anthocyanins and 3-deoxyanthocyanins. Grains of all the sorghums were found to be tannin-free. Malting decreased the TPC of all samples. For TPC, the grand means among all the sorghum cultivars for raw and malted grain were 2.77 and 2.48 mg gallic acid equivalents (GAE)/g, respectively. For flavan-4-ols, the grand means for raw and malted sorghum grains were 2.98 and 2.23 abs/mL/g, respectively. Remarkably, total anthocyanin levels more than doubled upon malting whereas total flavonoid levels decreased by 12%. The average abundance of 3-deoxyanthocyanins in raw sorghum grains increased for about 8-fold upon malting. Our results will be valuable for sorghum breeders in the selection of lines for specific end uses and for food scientists developing sorghum-based products.

The current trial was designed to examine effects of sequential feeding of diets varying in energy and protein contents on performance, gut development, welfare indices, and immune responses of broiler chicks. A total of 240 one-day-old broiler chicks (Ross 308) were randomly allotted to 4 treatments with 5 replicates in a completely randomized design. Sequential feeding was evaluated in 48-h cycles during 8 to 28 d of age. Diets varied in energy (E+ = 3,210 kcal/kg and E− = 2,790 kcal/kg) and protein (P+ = 25.14% CP and P− = 16.76% CP) contents. The 4 feeding programs were: control (ME: 3,000 kcal/kg, CP: 20.95%); P+/P− (P+ followed by P− containing 3,000 kcal/kg energy); E−/E+ (E− followed by E+ containing 20.95% CP), and E−P+ / E+P− (E−P+ followed by E+P−). The experiment lasted 42 d and birds were fed by a standard finishing diet from d 28 to 42. Broilers fed on E−/E+ and E−P+/E+P− had lower daily feed intake than control ones during 8 to 28 d of age (P < 0.05), while daily weight gain and feed conversion ratio were not affected significantly. Footpad dermatitis was lower in birds sequentially fed E−/E+ and E−P+/E+P− at 35 d of age (P < 0.05). Sequential feeding of diets varying in either energy or protein or both increased duration of tonic immobility at d 39 of age (P < 0.05). Feeding with E−/E+ regime decreased jejunal crypt depth, while feeding P+/P− regime increased villus height and crypt depth in the duodenum and ileum (P < 0.05). However, no relationship was found between intestinal morphology and growth performance of broiler chickens. Antibody production against sheep red blood cells as well as Newcastle and influenza disease viruses was not affected by sequential feeding. In conclusion, digestive organs and intestinal morphology might be adjusted to energy and protein variations. Sequential feeding increased the fear level in chickens.

The aim of this study was to investigate the effects of Fadrozole hydrochloride and recombinant human insulin-like growth factor I (rhIGF-I) on female-to-male sex reversal, hatching traits, and body weight of broiler chickens. On the third day of incubation, fertile eggs were randomly assigned to five experimental groups comprising (i) Fadrozole (0.1 mg/egg), (ii) rhIGF-I (100 ng/egg), (iii) Fadrozole (0.1 mg/egg) + rhIGF-I (100 ng/egg), (iv) vehicle injection (10 mM acetic acid and 0.1% BSA), and (v) non-injected eggs. Eggs in the rhIGF-I-injected groups showed the mode of hatching time at the 480th hour of incubation, 12 hours earlier compared to the other groups, with no statistically significant difference in mortality and hatchability. On Day 1 and 42 of production, 90% of genetically female chicks were masculinized using Fadrozole treatment, while 100% female-to-male phenotypic sex reversal was observed in the Fadrozole+rhIGF-I group. Fadrozole equalized the body weight of both genders, although rhIGF-I was effective on the body weight of male chicks only. Interestingly, combined rhIGF-I and Fadrozole could increase the body weight in both sexes compared to the individual injections (P<0.05). These findings revealed that (i) IGF-I-treated chicken embryos were shown to be an effective option for overcoming the very long chicken deprivation period, (ii) the simultaneous treatment with Fadrozole and IGF-I could maximize the female-to-male sex reversal chance, (iii) the increase in the body weight of masculinized chickens via Fadrozole could be equal to their genetically male counterparts, and (iv) the IGF-I effectiveness, specifically along with the application of aromatase inhibitors in female chicks, indicates that estrogen synthesis could be a stumbling block for the IGF-I action mechanism in female embryos.